Skip to Main Content

Author Details

Eric D Peterson
University of Texas Southwestern Medical Center
1994
1479
164
PMIDPaper TitleJournal TitlePublished Year
37699726Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China.Stroke Vasc Neurol2024
37699726Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China.Stroke Vasc Neurol2024
36322056Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice.JAMA Cardiol2023
36350615Can System Solutions Be Scaled to Control High Blood Pressure and Lipids?JAMA Cardiol2023
36322056Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice.JAMA Cardiol2023
37596725Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries.Clin Cardiol2023
37874574Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.JAMA2023
37552540Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes.JCI Insight2023
37610733Health Claims and Doses of Fish Oil Supplements in the US.JAMA Cardiol2023
37338878Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke.JAMA2023
37029056Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice.J Clin Lipidol2023
37025553Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes.Am J Prev Cardiol2023
36642226Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study.Am Heart J2023
37017940Modeling the Association of Volume vs Composite Outcome Thresholds With Outcomes and Access to Transcatheter Aortic Valve Implantation in the US.JAMA Cardiol2023
37196972Generalizability of an EHR-network dataset to the United States for cardiovascular disease conditions: Comparison of Cerner real world data with the national inpatient sample.Am Heart J2023
37011387Facilitating Shared Decision Making Among Black Patients at Risk for Sudden Cardiac Arrest : A Randomized Clinical Trial.Ann Intern Med2023
36997096Evaluation of weight change and cardiometabolic risk factors in a real-world population of US adults with overweight or obesity.Prev Med2023
37301758Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial.J Am Heart Assoc2023
37529931Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322â¿¿153 Patients.Circ Cardiovasc Qual Outcomes2023
37036906Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure.Circulation2023
36978066Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.Cardiovasc Diabetol2023
37529931Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322â¿¿153 Patients.Circ Cardiovasc Qual Outcomes2023
37596725Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries.Clin Cardiol2023
37552540Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes.JCI Insight2023
37610733Health Claims and Doses of Fish Oil Supplements in the US.JAMA Cardiol2023
37874574Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.JAMA2023
37025553Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes.Am J Prev Cardiol2023
37017940Modeling the Association of Volume vs Composite Outcome Thresholds With Outcomes and Access to Transcatheter Aortic Valve Implantation in the US.JAMA Cardiol2023
36978066Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.Cardiovasc Diabetol2023
37011387Facilitating Shared Decision Making Among Black Patients at Risk for Sudden Cardiac Arrest : A Randomized Clinical Trial.Ann Intern Med2023
37338878Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke.JAMA2023
37036906Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure.Circulation2023
37301758Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial.J Am Heart Assoc2023
37196972Generalizability of an EHR-network dataset to the United States for cardiovascular disease conditions: Comparison of Cerner real world data with the national inpatient sample.Am Heart J2023
37029056Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice.J Clin Lipidol2023
36997096Evaluation of weight change and cardiometabolic risk factors in a real-world population of US adults with overweight or obesity.Prev Med2023
36642226Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study.Am Heart J2023
36350615Can System Solutions Be Scaled to Control High Blood Pressure and Lipids?JAMA Cardiol2023
33394360The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19.Cardiovasc Drugs Ther2022
36250667Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out-Of-Pocket Expenses? Insights From ARTEMIS.J Am Heart Assoc2022
35656988Validation of the WATCH-DM and TRS-HF<sub>DM</sub> Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis.J Am Heart Assoc2022
35654018Differences in ejection fraction as inclusion criterion in randomized controlled trials among patients with heart failure with reduced ejection fraction: a systematic review.Expert Rev Cardiovasc Ther2022
35512864Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison.J Am Coll Cardiol2022
35900761Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke.JAMA Netw Open2022
36030198Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.Cardiovasc Diabetol2022
36346063Trends in Oral Anticoagulant Use Among 436â¿¿864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020.J Am Heart Assoc2022
36154237Ninety-Day Risk-Standardized Home Time as a Performance Metric for Cardiac Surgery Hospitals in the United States.Circulation2022
35635767The HEART Pathway: Just a HEART score permutation or the future of clinical decision rules?Acad Emerg Med2022
35997751Statin Recommendations for Primary Prevention: More of the Same or Time for a Change?JAMA2022
35934528Corrigendum to "Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease" [Am Heart J (2021) 231:36-44].Am Heart J2022
  • 1 - 50 of 2,958

Recommended Authors

Medhat Farwati
Cleveland Clinic Foundation, Vascular and Thoracic Institute
Career Start Year 2018
Number of shared co-authors 2
Dhruv Mahtta
Baylor College of Medicine
Career Start Year 2017
Number of shared co-authors 14
Chayakrit Krittanawong
NYU Langone Health and NYU School of Medicine
Career Start Year 2016
Number of shared co-authors 15
Abdul H Qazi
Massachusetts General Hospital
Career Start Year 2015
Number of shared co-authors 4
Suveen Angraal
Cardiovascular medicine clinical fellow at the Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 11
Alexander T Sandhu
Department of Medicine Stanford University Stanford CA USA.
Career Start Year 2015
Number of shared co-authors 13
Prakriti Gaba
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2014
Number of shared co-authors 11
Elizabeth L Nichols
The Dartmouth Institute for Health Policy and Clinical Practice
Career Start Year 2014
Number of shared co-authors 9
Andrew E Levy
University of Colorado Anschutz Medical Campus
Career Start Year 2014
Number of shared co-authors 5
Xiaoxi Yao
Department of Cardiovascular Medicine Mayo Clinic Rochester MN.
Career Start Year 2014
Number of shared co-authors 12
Auras R Atreya
AIG Hospitals Institute of Cardiac Sciences and Research
Career Start Year 2011
Number of shared co-authors 0
Eric A Secemsky
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2011
Number of shared co-authors 46
Karthik Murugiah
Center for Outcomes Research and Evaluation, Yale New Haven Hospital
Career Start Year 2010
Number of shared co-authors 12
Sourbha S Dani
Lahey Hospital and Medical Center
Career Start Year 2010
Number of shared co-authors 19
Bryan Har
Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary
Career Start Year 2009
Number of shared co-authors 3
Rohan Khera
Yale School of Medicine
Career Start Year 2009
Number of shared co-authors 37
Aakriti Gupta
Yale/YNHH Center for Outcomes Research and Evaluation (CORE)
Career Start Year 2008
Number of shared co-authors 19
Neil J Wimmer
VA Boston Healthcare System
Career Start Year 2007
Number of shared co-authors 18
Kevin F Kennedy
Saint Luke's Mid America Heart Institute
Career Start Year 2004
Number of shared co-authors 66
Donald S Likosky
Section of Health Services Research and Quality
Career Start Year 2003
Number of shared co-authors 12
Stephen W Waldo
Department of Veterans Affairs Clinical Assessment
Career Start Year 2003
Number of shared co-authors 33
Joseph A Ladapo
University of Florida College of Medicine
Career Start Year 2002
Number of shared co-authors 7
Jeremiah R Brown
Geisel School of Medicine at Dartmouth
Career Start Year 2000
Number of shared co-authors 22
Michelle M Graham
University of Alberta
Career Start Year 1999
Number of shared co-authors 12
Erica S Spatz
Yale School of Medicine
Career Start Year 1998
Number of shared co-authors 33
Anthony A Bavry
Division of Cardiology University of Texas Southwestern Medical Center Dallas TX USA.
Career Start Year 1996
Number of shared co-authors 19
Stephen E Kimmel
University of Florida
Career Start Year 1995
Number of shared co-authors 21
Derek B Boothroyd
Stanford University School of Medicine
Career Start Year 1993
Number of shared co-authors 6
William A Ghali
Cumming School of Medicine, University of Calgary
Career Start Year 1988
Number of shared co-authors 3
David J Maron
Stanford University School of Medicine
Career Start Year 1981
Number of shared co-authors 35

Collaborators

Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 340
Matthew T Roe
Duke Clinical Research Institute, Duke University
Co-authored papers 209
Adrian F Hernandez
Duke University Medical Center
Co-authored papers 186
Tracy Y Wang
Duke University
Co-authored papers 168
Deepak L Bhatt
Icahn School of Medicine at Mount Sinai Health System
Co-authored papers 132
Erik Magnus Ohman
Duke University Medical Center-Duke Clinical Research Institute
Co-authored papers 122
Lee H Schwamm
Massachusetts General Hospital
Co-authored papers 117
Jonathan P Piccini
Duke University, NC Duke Clinical Research Institute
Co-authored papers 107
Sean M O'Brien
West Virginia University
Co-authored papers 103
W Brian Gibler
University of Cincinnati College of Medicine President
Co-authored papers 97
John S Rumsfeld
Stanford University
Co-authored papers 93
Robert M Califf
From the National Institutes of Health
Co-authored papers 90
Kenneth W Mahaffey
Stanford University Medical School
Co-authored papers 87
Christopher P Cannon
Brigham and Women's Hospital
Co-authored papers 85
Bernard J Gersh
Mayo Clinic College of Medicine and Science
Co-authored papers 80
Eric E Smith
Cumming School of Medicine, University of Calgary
Co-authored papers 78
Robert A Harrington
Co-authored papers 72
Ann Marie Navar
UT Southwestern Medical Center
Co-authored papers 70
Charles V Pollack
Thomas Jefferson University Hospital, Pennsylvania Sidney Kimmel Medical College
Co-authored papers 69
Paul A Heidenreich
Stanford University School of Medicine
Co-authored papers 68
Ralph G Brindis
University of California san francisco
Co-authored papers 65
Elizabeth R DeLong
Duke University
Co-authored papers 64
Fred H Edwards
University of Florida College of Medicine Jacksonville
Co-authored papers 64
David M Shahian
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 62
Thomas Bruce Ferguson
Brody School of Medicine, East Carolina University
Co-authored papers 61
Frederick A Masoudi
University of Colorado School of Medicine
Co-authored papers 60
Renato D Lopes
Duke Clinical Research Institute, Duke University
Co-authored papers 59
John A Spertus
University of Missouri-Kansas City School of Medicine
Co-authored papers 59
David Dai
Duke University Medical Center
Co-authored papers 57
Harlan M Krumholz
Yale School of Medicine
Co-authored papers 53
Release 1.2